Medtech Archives

News and Trends 31 Aug 2016

World’s most advanced Artificial Heart started its last Study before Approval

This artificial heart could replace any defective heart. It’s being developed by the French company Carmat, which just started the last clinical phase before market approval. Carmat is solving one of the life-long problems for humans, how to replace a broken heart. It’s not the first to offer a solution (e.g. Robert Jarvik in the US), […]

August 31, 2016 - 3 minutesmins - By Philip Hemme

News and Trends 31 Aug 2016

No Tumour, No Cancer Cure: New Epigenetic Test can pinpoint Elusive Ones

Not all tumours are detectable, which makes them particularly deadly. Researchers at the University of Barcelona have developed an epigenetic test to find them, the first of its kind to diagnose tumour sources. Cancer starts with a tumour, which grows and eventually sheds cells. These cells lodge in other tissues in the body and grow […]

August 31, 2016 - 3 minutesmins - By Evelyn Warner

News and Trends 29 Aug 2016

Maybe you don’t need Chemo: NEJM hails MammaPrint as Diagnostic Tool

About 46% of women with breast cancer may not need chemotherapy. An article in the New England Journal of Medicine describes a new assay from Agendia, MammaPrint, could save them the pain of this toxic treatment. Personalizing medicine is a major focus in the development of ever more precise treatments, and it is particularly relevant […]

August 29, 2016 - 2 minutesmins - By Evelyn Warner

galvani bioelectronics electroceuticals gsk verily google

News and Trends 2 Aug 2016

Google and GSK invest €630M to create a new Bioelectronics Champion

GSK and Verily Life Sciences are creating a new company together, Galvani Bioelectronics. Along with €630M in investment, it’ll inherit intellectual property to pioneer a new class of therapies – bioelectronic medicines. GSK is one of the big Pharma based in Europe and has had a strong presence in many hype fields of medical Biotech. Examples are […]

August 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

why lithuania biotech baltic life sciences

News and Trends 26 Jul 2016

What is Lithuania’s role in European Biotech?

Since the days of the Soviet Union, Lithuania has always been considered as a leader in life sciences discoveries in Eastern Europe due to its infrastructure. But what about for Biotech? Nowadays, as a member of the NATO, the European Union, and Eurozone, Lithuania’s life science sector is growing around 20-25% annually; with special focus on […]

July 26, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 14 Jul 2016

Sci-fi Spinal Cord Implant could help Paralyzed Patients walk again

Getting up from a wheelchair is a shared dream of paralyzed people all across the world. A dream that might soon become true thanks to a new skin-like implant that directly stimulates the patients’ spinal cord through electric pulses. The sci-fi technology developed by researchers at École Polytechnique Fédérale of Lausanne (EPFL) in Switzerland has […]

July 14, 2016 - 2 minutesmins - By Lourdes Riquelme

HIV diagnostic helen lee epo biotech inventor europe samba

News and Trends 12 Jul 2016

How did Helen Lee overcome barriers to HIV Diagnostics in the ‘Real World’?

How can diagnostics be improved in resource limited settings? And how can the practical limitations of transporting heat-sensitive assay material through hot climates be overcome? The University of Cambridge’s Dr Helen Lee won this year’s ‘Popular Choice’ Award, at the European Patent Office (EPO) awards. The winner of this prize category is selected from 15 other […]

July 12, 2016 - 6 minutesmins - By Dani Bancroft

biogeneration capital ventures finance money fund biotech medtech

News and Trends 5 Jul 2016

The Fund behind the ‘Biggest Private Exit Ever’ to Raise another €50M

BioGeneration Ventures has had its first close of a new venture capital fund, ‘BioGeneration Capital Fund III’, for novel diagnostic, medtech and therapeutic biotechs in Europe. BioGeneration Ventures (BGV) is based in Naarden (Netherlands) and manages funds investing in Netherlands, Belgium and Germany. Some of its biotech porfolio companies have included Dezima Pharma (acquired by Amgen from […]

July 5, 2016 - 2 minutesmins - By Dani Bancroft

eva daignostics startup battle labiotech refresh biotech

News and Trends 15 Jun 2016

Eva Diagnostics: “We identified the pain points of the Blood testing market” #LBRefresh

Eva Diagnostics was one of the contestants at our Startup Battle during Labiotech Refresh. Take a second look with us at the pitch of Eva’s exciting diagnostic Tech… We had Sabine Dziemian, the head of data analysis at Eva Diagnostics, explain how this spin-off out of Imperial College London is joining the race for MedTech diagnostics. […]

June 15, 2016 - 2 minutesmins - By Denise Neves Gameiro

diabetes glucose chronic disease biotech pharma review

News and Trends 14 Jun 2016

Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.

Given the rates of diabetes reaching ‘epidemic proportions’, we figured it was time to have a better overview of biotech’s progress in the field. With some serious advances having been made in the treatment of the disease, we have to ask – how much further can biotech go in the treatment of diabetes? It is important […]

June 14, 2016 - 9 minutesmins - By Dani Bancroft

News and Trends 13 Jun 2016

Italy cures Diabetes with new Engineered Mini-organs

Ospedale Niguarda Ca’ Granda has succeeded in treating a patient with type 1 diabetes, using a new tissue engineering techniques for more effective islet transplants – something that could bring this diabetes cure to more patients. Biotech is tackling diabetes from several fronts – from mitigation of symptoms, for example, Avita’s skin spray, to medtech inventions […]

June 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

numab intarcia antibodies implantable drug delivery

News and Trends 6 Jun 2016

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

Numab and Intarcia have achieved key milestones in the development of therapeutic antibody fragments. This collaboration could span the next generation of implantable drug delivery tech for diabetes, obesity and autoimmune diseases. Based in Wädenswill (near Zurich), Numab is developing antibody-based therapeutics. With its ultra-high throughput technology, it can find rare molecules with big therapeutic potential that are […]

June 6, 2016 - 2 minutesmins - By Denise Neves Gameiro

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us